Lisinopril and Hydrochlorothiazide Tablets USP — Class II drug recall D-1581-2019
Terminated recall by Lupin Pharmaceuticals Inc., reported 2019-07-31, distributed nationwide. Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 5
| Recall number | D-1581-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Pharmaceuticals Inc., Baltimore, MD, United States |
| Recall initiated | 2019-07-19 |
| Classified | 2019-07-31 |
| Reported by FDA | 2019-07-31 |
| Terminated | 2020-09-09 |
| Distributed | Nationwide (US) |
| Quantity | 11,832 bottles |
| NDC | 68180-0518, 68180-0518-01, 68180-0518-02, 68180-0518-30, 68180-0519, 68180-0519-01, 68180-0519-02, 68180-0519-30, 68180-0520, 68180-0520-01, 68180-0520-02, 68180-0520-30 |
| Lot numbers | H801815 |
| Expiration dates | 2021-03-20 |
Product
Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg, 500-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA, NDC 68180-519-02
Reason for recall
Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1581-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.